Dr Reddys Labs Launches Generic Venlafaxine Er Tablets
Dr Reddys Laboratories Ltd Has Announced The Launch Of Us Food And Drug Administration (Fda) Approved Venlafaxine Er Tablets Which Is Therapeutically Equivalent To Venlafaxine Extended-Release Tablets, 150 Mg And 225 Mg, Of Osmotica Pharmaceutical Us Llc. The Brand And Generic Had Us Sales Of Approximately Us$ 51 Million Mat For The Most Recent Twelve Months Ending In October 2021 According To Iqvia Health. Dr Reddy'S Venlafaxine Er Tablets Are Available In 150 Mg And 225 Mg Strengths In Bottle Count Sizes Of 30 And 90.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
